A previous study reported that lymphopenia in SARS may be due to enhanced vascular sequestration associated with increased soluble vascular cell adhesion molecule-1 levels [25], but the mechanism is not clear in patients with COVID-19. This evidence concerns the gene VCAM1 and COVID-19.